Trial intelligence / Profile preview

Top Down Versus Step Up Strategies in Crohn's Disease

NCT00554710Phase 4Completed

Sponsor
Belgian IBD Research and Development
Start
May 2001
Modality
Small Molecules, Monoclonal Antibodies
Countries
1
01

Overview

A Phase 4 trial of infliximab, azathioprine in Crohn's disease, sponsored by Belgian IBD Research and Development. Started May 2001; status: completed.

02

Drugs

infliximabazathioprine
03

Conditions

Crohn's disease

Beyond the preview

Go deeper on NCT00554710.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00554710.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call